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regurgitation
D. Rizwan, S. Badhe *, L. Anand, V.R. Iyer, P.K. Dash
Department of Cardiology, Sri Sathya Sai Institute of Higher Medical
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Background: Rheumatic cardiac disease is an immunologic phe-
nomenon that may affect any of the heart valves and is by far the
most common cause of mitral stenosis.
Aims & objectives: To study the immediate and delayed effects of
successful PTMC on global RV function in patients with mitral
stenosis with or without mild MR.
Methods: 100 consecutive patients who underwent balloon mitral
valvuloplasty for rheumatic mitral stenosis between May 2013 and
May 2014 at Sri Satya Sai Institute of Higher Medical Sciences
Prasanthigram, Ananthpur district. All patients were subjected
to clinical examination, transthoracic echo Doppler study and
tissue Doppler imaging for: (A) assessment of severity of mitral
stenosis; (B) assessment of systolic and diastolic function.
Results:
(1) Post PTMC there is a signiﬁcant reduction in the TR and a
signiﬁcant increase in MR.
(2) Successful PTMC was associated with a signiﬁcant reduc-
tion in the Wilkins score, peak and mean mitral gradient.
(3) Follow-up after 6months for the peak gradient showed not
much difference but there was a signiﬁcant reduction in
the mean gradient.
(4) There is a signiﬁcant improvement in themitral valve area
which continues even after the period of 6 months.
(5) Right ventricular systolic pressure immediately after PTMC
reduces statistically but this reduction is not carried after 6
months.
(6) Post PTMC there is a signiﬁcant increase in the fractional
area change and this increase persists up the period of 6
months.
(7) TAPSE that reﬂect systolic function of RV, changes
signiﬁcantly after PTMC but this change are not present
at 6 months follow-up.
(8) The RV TVI S', E and A values increase immediately after
PTMC but there is no sustained improvement after 6
months.
Conclusion: The current study showed a signiﬁcant improvement
in both systolic and diastolic functions of RV as observed by
different echocardiographic parameters post BMV.
An unusual complication of mitral
valve infective endocarditis in a child
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Aterio-ventricular ﬁstula due to infective endocarditis (IE) invol-
ving non-mitral–aortic intervalvular fossa is a rare entity. We
present a case of IE of mitral valve complicated by pseudo aneur-
ysm of posterior wall of left atrium (LA) and posterior mitral
annulus ﬁstulizing to left ventricle (LV) and LA, best visualized
by three dimensional transthoracic echocardiogram (3DTTE).
3-years-old boy presented with past history of completed treat-
ment of IE of mitral valve one-year back. Child was asymptomatic
after that. Transthoracic echocardiogram showed hypoechoic cav-
ity in the posterior mitral annulus and posterior wall of left atrium
ﬁstulizing to LV through an oriﬁce in mitral annulus suggestive of
pseudoaneurysm and had moderate mitral regurgitation. 3DTTE
conﬁrmed the presence of mitral annulus pseudoaneurysm ﬁstu-
lizing to LV and LA.
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Background: Although many patients with valvular heart disease
have concomitant coronary artery disease (CAD), there are limited
data on the association between rheumatic valvular disease (RVD)
and CAD. Aim of this study was to determine the prevalence of
coronary artery disease in patients with rheumatic heart disease
undergoing valve surgery.
Methods and results: Total 188 consecutive patients with rheu-
matic heart disease who were above the age of 40 years, and
scheduled for valve surgery underwent diagnostic coronary angio-
gram to delineate coronary arteries. The patients were divided into
three groups based on valve involvement (mitral valve, aortic
valve, and combined aortic and mitral valve). Signiﬁcant coronary
artery disease was considered to be present if one or more cor-
onaries showed 50% or more luminal stenosis. There were 144
(76.5%) males and 44 (23.5%) females. The mean age of the study
population was 51.2  8.2 years. 44 (23.5%) patients had typical
chest pain, 58 (30.8%) patients had atypical chest pain and 86
(45.7%) patients had no chest pain. Hypertension was noted in
44 (23.4%) patients, 33 (17.5%) patients had diabetes, 49 (26.1%)
patients were smoker, and 33 (17.5%) patients had dyslipidemia,
and 8 (4.2%) patients gave past history of myocardial infarction. Of
the total 188 patients, 23 (12.2%) patients were found to have
signiﬁcant coronary artery disease. In patients with mitral valve
disease the prevalence was 14.58% (7/48), while it was 16.1% (10/62)
in patients with aortic valve disease and 8.9% (7/78) in those with
combined mitral and aortic valve disease.
Table 1 – Baseline characteristics.
Risk factors Total
(n = 188)
Male
(n = 144)
Female
(n = 44)
P value
Chest pain (typical) 44 (23.5) 38 (26.5) 6 (14.6) 0.01*
Chest pain (atypical) 58 (30.8) 47 (32.7) 11 (24.7) 0.09
No chest pain 85 (45.5) 59 (40.8) 27 (60.6) 0.001*
Hypertension 44 (23.4) 36 (25.4) 8 (16.9) 0.06
Diabetes mellitus 32 (17.3) 25 (17.8) 7 (15.7) 0.4
Smoking 49 (26.1) 47 (32.8) 2 (4.5) 0.001*
Dyslipidemia 33 (17.6) 26 (18.1) 7 (15.7) 0.37
Past MI 15 (4.0) 8 (5.5) 7 (15.9) 0.09
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Conclusions: The overall prevalence of coronary artery disease in a
study group of patients with rheumatic heart disease undergoing
valve surgery in western India in single centre is 12.2%. This
prevalence is much lower than the ﬁgures reported earlier in
the Western literature.
Risk factor profile in degenerative aortic
stenosis with and without associated
CAD
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Background: Degenerative aortic stenosis (DAS) and coronary
artery disease (CAD) share common risk factors. In some of the
previous studies statins have been used to retard the progression
of aortic stenosis, but the results are inconsistent
Objective (aim): To study the risk factor proﬁle in degenerative
aortic stenosis with and without associated CAD.
Methods: One hundred and ten patients of DAS above the age of
40 years have undergone clinical, biochemical and echocardio-
graphic evaluation. Coronary angiograms were done in 68% of
the cases.
Results: Male to female ratio is 2:1. Patients of DAS with CAD
showed higher prevalence of diabetes, hypertension, dyslipide-
mia, smoking and family history of CAD. Prevalence of obesity and
bicuspid aortic valve by echocardiogramwas high in those without
CAD.
Conclusion: Our observations are in agreement with those of Kora/
Monica and SEAS studies but the prevalence of diabetes is high in
our study. This is the ﬁrst Indian study to study the risk factor
proﬁles in cases of DAS.
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Severe MS is usually symptomatic and is treated by BMV or sur-
gery, whereas mild to moderate mitral stenosis is usually asymp-
tomatic or mildly symptomatic and managed medically. Patients
in the latter group may become symptomatic during episodes of
exercise and increased heart rate. As increase in heart rate occurs
mostly at the expense of diastole, there is shortening of the
diastolic ﬁlling period, and in the presence of obstruction at the
mitral valve this results in increased left atrial pressure. Subse-
quently, pulmonary capillary wedge pressure rises, resulting in
effort intolerance and dyspnea. Theoretically, negative chronotro-
pic agents such as blockers and CCBs should be helpful in con-
trolling tachycardia-related symptoms by improving diastolic
ﬁlling and preventing rise in pulmonary capillary wedge pressure.
However, associated negative inotropic effect on myocardium and
effect on neuromuscular system may negate the beneﬁcial effects
of these drugs. CCBs have little role in controlling heart rate when
the patient is in sinus rhythm. Results from various clinical and
hemodynamic studies with these agents have been conﬂicting.
We studied 97 patients of mitral stenosis in sinus rhythm pre-
sented with exertional symptoms. The effectiveness of metoprolol
is compared with ivabradin in alleviating these exertional symp-
toms in a randomized, open label non cross over study. We also
assessed various stress ECG parameters, 24 hr Holter parameters
and 2D echo parameters to objectively compare the effect of
ivabradin and metoprolol in these patients. The ﬁndings are as
follows:
 Ivabradin and metoprolol both are effective in controlling
exertional symptoms.
 Signiﬁcant improvement in objective parameters like TMT
(work capacity, baseline heart rate and maximum heart
rate), 24 hr Holter (minimum heart rate, average heart rate
and maximum heart rate) and 2D echocardiography (right
ventricular systolic pressure) are seen with both drugs.
 Ivabradin control the exertional symptoms signiﬁcantly
more than metoprolol.
 Objective parameters improve signiﬁcantly more with ivab-
radin than metoprolol except average heart rate reduction.
Conclusion: Ivabradin is better than metoprolol in medical man-
agement of mitral stenosis patients Ivabradin should be strongly
Table 2 – Distribution of valve lesions and coronary artery
disease.
Valve involved Total no.
of patients
(%) of patients
with CAD
Mitral valve 7 13.5
Aortic valve 62 15.3
Combined 7 9.0
Total 188 12.2
Table 3 – Reported prevalence of coronary artery disease
in mitral valve disease.
Author Year No. of patients
Reported
Studied
prevalence (%)
Befeler et al. 1970 26 50
Lacy et al. 1977 67 32
Baxter et al. 1978 82 22
Saltups 1982 100 23
Chun et al 1982 82 26
Czer et al. 1984 56 27
Mattina et al. 1986 96 28
CMC Vellore 2003 96 13.5
Table 4 – Reported prevalence of coronary artery disease
in aortic valve disease.
Author Year No. of patients
reported
Studied
prevalence (%)
Coleman & Soloff 1970 77 17.7
Harris et al. 1975 69 23.2
Baxter et al. 1978 47 17
Vandeplas et al. 1988 192 24
Ravi Kishore et al. 1988 106 5.6
CMC Vellore 2003 124 15.3
Saltups 1982 100 30
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